Elly Margaret Tanaka | |
---|---|
Born | Elly Margaret Tanaka |
Alma mater | |
Awards |
|
Scientific career | |
Fields | molecular biology, regeneration |
Institutions |
|
Thesis | (1993) |
Doctoral advisor | Marc W. Kirschner |
Website | www |
Elly Margaret Tanaka (born 22 August 1965) is a biochemist and Scientific Director at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) in Vienna, Austria. Tanaka studies the molecular cell biology of limb and spinal cord regeneration as well as the evolution of regeneration.
Tanaka was born in Boston, Massachusetts, and obtained a bachelor's degree in biochemistry from Harvard University in 1987 and a PhD from the University of California, San Francisco in 1993, where she had worked in the lab of Marc W. Kirschner. [1] She then became a postdoctoral researcher in the lab of Jeremy Brockes at University College London and Ludwig Institute. [1]
Tanaka started her own lab at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden (Germany) in 1999. [1] Her research focused on axolotl spinal cord regeneration. [1]
In 2008, Tanaka became a professor at the Center for Regenerative Therapies Dresden (CRTD) of the Technische Universität Dresden. [1] She became director of the center in 2014, [2] before becoming senior scientist at the Research Institute of Molecular Pathology (IMP) in Vienna in 2016. [3] In 2024, Tanaka joined the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) as Scientific Director. [4] The Mexican salamander species axolotl is Tanaka's main model system for her research and is also working to translate them to mouse and human tissue. [5] Using innovative molecular biology and microscopy methods, she identified those stem cells that underlie the regeneration of limbs and the spinal cord. [6] She is a member of the Editorial Board for Developmental Cell . [7]
Tanaka was elected a member of the Academia Europaea in 2015, [2] of the European Molecular Biology Organisation in 2017, the Austrian Academy of Sciences in 2021, [8] [9] the National Academy of Sciences in 2023 [10] and the German National Academy of Sciences Leopoldina in 2024. [11] She was awarded the Ernst Schering Prize in 2017, highlighting Tanaka as "the leading expert in the field of regeneration biology". [6] In 2018, she was awarded the Erwin Schrödinger Prize of the Austrian Academy of Sciences for lifetime achievements. [12] In 2020, she was awarded the FEBS | EMBO Women in Science Award. [13]
Regeneration in biology is the process of renewal, restoration, and tissue growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Every species is capable of regeneration, from bacteria to humans. Regeneration can either be complete where the new tissue is the same as the lost tissue, or incomplete after which the necrotic tissue becomes fibrotic.
The Gregor Mendel Institute of Molecular Plant Biology (GMI) is a basic research institute in Vienna, Austria. It was founded in 2000 by the Austrian Academy of Sciences (ÖAW) to promote cutting-edge research in the field of molecular plant biology. The GMI employs about 130 people. Its founding director was Dieter Schweizer, and the current scientific director is Magnus Nordborg. The institute is named after Gregor Mendel, who is also known as the "Father of genetics," due to his scientific work and the fact that he studied at the University of Vienna in the mid-19th century.
Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.
The Research Institute of Molecular Pathology (IMP) is a biomedical research center, which conducts curiosity-driven basic research in the molecular life sciences.
The Institute of Molecular Biotechnology (IMBA) is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter (VBC) and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.
Anthony Arie Hyman is a British scientist and director at the Max Planck Institute of Molecular Cell Biology and Genetics.
Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.
Maria Leptin is a German developmental biologist and immunologist, and the current President of the European Research Council. She was the Director of the European Molecular Biology Organization from 2010 to 2021.
The Ernst Schering Prize is awarded annually by the Ernst Schering Foundation for especially outstanding basic research in the fields of medicine, biology or chemistry anywhere in the world. Established in 1991 by the Ernst Schering Research Foundation, and named after the German apothecary and industrialist, Ernst Christian Friedrich Schering, who founded the Schering Corporation, the prize is now worth €50,000.
Max Luciano Birnstiel was a Swiss molecular biologist who held a number of positions in scientific leadership in Europe, including the chair of the Institute of Molecular Biology at the University of Zurich from 1972–86, and that of founding director of the Research Institute of Molecular Pathology (IMP) in Vienna from 1986 to 1996. His research focused on gene regulation in eukaryotes. His research group is sometimes cited as the first to purify single genes, the ribosomal RNA genes from Xenopus laevis, three years before the successful isolation of the lac operon. He is also recognized for one of the earliest discoveries of a gene enhancer element. Birnstiel died in 2014 of heart failure during cancer treatment.
Petra Schwille is a German professor and a researcher in the area of biophysics. Since 2011, she has been a director of the Department of Cellular and Molecular Biophysics at the Max Planck Institute for Biochemistry in Martinsried, Germany. She is known for her ground-laying work in the field of fluorescence cross-correlation spectroscopy, and numerous contributions on model membranes. Her current research focuses around bottom-up approaches to building an artificial cell within a broader area of synthetic biology. In 2010, Schwille received the Gottfried Wilhelm Leibniz Prize.
The Vienna BioCenter is a cluster of life science research institutes and biotechnology companies located in the 3rd municipal District of Vienna, Austria. It grew around the Research Institute of Molecular Pathology (IMP), which opened in 1988. The entities at the Vienna BioCenter employ more than 2,000 people, including 600 students.
Denise P. Barlow was a British geneticist who worked in the field of epigenomics. Barlow was an elected member of European Molecular Biology Organization (EMBO), an honorary professor of genetics at the University of Vienna and recipient of the Erwin Schrödinger Prize of the Austrian Academy of Sciences. In 1991, she discovered the first mammalian imprinted gene, IGF2R, which codes for the insulin-like growth factor.
Catherina Gwynne Becker is W3 professor for Neural Development and Regeneration Alexander von Humboldt Professor at TU Dresden, and was formerly Professor of Neural Development and Regeneration at the University of Edinburgh.
Jürgen Knoblich is a German molecular biologist. Since 2018, he is the interim Scientific Director of the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Daniel Wolfram Gerlich is a German cell biologist. Since 2012 he has been a Senior Group Leader at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Julius Brennecke is a German molecular biologist and geneticist. He is a Senior Group Leader at the Institute of Molecular Biotechnology. (IMBA) of the Austrian Academy of Sciences in Vienna.
Dedifferentiation is a transient process by which cells become less specialized and return to an earlier cell state within the same lineage. This suggests an increase in cell potency, meaning that, following dedifferentiation, a cell may possess the ability to re-differentiate into more cell types than it did before dedifferentiation. This is in contrast to differentiation, where differences in gene expression, morphology, or physiology arise in a cell, making its function increasingly specialized.
Sabine Werner is a German biochemist and professor.